Suchen
MDxHealth SA
MDXHZur Watchlist hinzufügen
0.507USD
+0.096+23.48%
Handelsschluss 07/01, 16:00（ET）Kurse um 15 Minuten verzögert
26.04MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über MDxHealth SA Unternehmen
MDxHealth SA is a Belgium-based healthcare company which provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The Company’s tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, as well as prediction of response to a specific therapy. Its tests include ConfirmMDx for Prostate Cancer, SelectMDx for Prostate Cancer, PredictMDx for Glioblastoma and AssureMDx for Bladder Cancer. The Company's corporate operations are based in Herstal, Belgium, as well as Irvine, the United States, and its laboratory operations are based in Nijmegen, the Netherlands, as well as Irvine, the United States.
MDxHealth SA Informationen
BörsenkürzelMDXH
Name des UnternehmensMDxHealth SA
IPO-datumJun 26, 2006
CEOMr. Michael K. McGarrity
Anzahl der mitarbeiter312
WertpapierartOrdinary Share
GeschäftsjahresendeJun 26
AddresseCAP Business Center
StadtHERSTAL
BörseNASDAQ Capital Market Consolidated
LandBelgium
Postleitzahl4040
Telefon3243642070
Websitehttps://mdxhealth.com/
BörsenkürzelMDXH
IPO-datumJun 26, 2006
CEOMr. Michael K. McGarrity
Führungskräfte von MDxHealth SA
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Michael K. McGarrity
Mr. Michael K. McGarrity
Chief Executive Officer, Director
Chief Executive Officer, Director
95.00K
--
Mr. Michael Holder
Mr. Michael Holder
Director
Director
--
--
Mr. Mark Shaffar
Mr. Mark Shaffar
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Christopher (Chris) Thibodeau
Mr. Christopher (Chris) Thibodeau
Executive Vice President & U.S. Chief Operations Officer
Executive Vice President & U.S. Chief Operations Officer
--
--
Dr. Sanford S Siegel, M.D.
Dr. Sanford S Siegel, M.D.
Director
Director
--
--
Mr. Joseph (Joe) Sollee
Mr. Joseph (Joe) Sollee
Executive Vice President, Chief Compliance Officer, General Counsel
Executive Vice President, Chief Compliance Officer, General Counsel
--
--
Mr. John Bellano
Mr. John Bellano
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Rudi Marien
Mr. Rudi Marien
Non-Executive Director
Non-Executive Director
--
--
Mme. Ruth Devenyns
Mme. Ruth Devenyns
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Walter M. (Wally) Narajowski
Mr. Walter M. (Wally) Narajowski
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Michael K. McGarrity
Mr. Michael K. McGarrity
Chief Executive Officer, Director
Chief Executive Officer, Director
95.00K
--
Mr. Michael Holder
Mr. Michael Holder
Director
Director
--
--
Mr. Mark Shaffar
Mr. Mark Shaffar
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Christopher (Chris) Thibodeau
Mr. Christopher (Chris) Thibodeau
Executive Vice President & U.S. Chief Operations Officer
Executive Vice President & U.S. Chief Operations Officer
--
--
Dr. Sanford S Siegel, M.D.
Dr. Sanford S Siegel, M.D.
Director
Director
--
--
Mr. Joseph (Joe) Sollee
Mr. Joseph (Joe) Sollee
Executive Vice President, Chief Compliance Officer, General Counsel
Executive Vice President, Chief Compliance Officer, General Counsel
--
--
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von MDxHealth SA?
Die fünf größten Anteilseigner von MDxHealth SA sind: Mr. Michael K. McGarrity
Wie viele Institutionen halten Anteile an MDxHealth SA (MDXH)?
Mit Stand vom 2026Q1 halten 91 Institutionen Anteile an MDxHealth SA, mit einem Gesamtmarktwert von etwa 25.38M, was 49.41% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -275861.00 gestiegen.